Medpace Holdings, Inc. (MEDP) stock: price, suppliers, customers and institutional ownership
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Medpace Holdings, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Services-Commercial Physical & Biological Research
High 613.21 at 11:00 am ET, low 609.83 at 3:00 pm ET.
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
the bull case· 4
4
disclosed supplier and customer ties in SEC filings
sec filingsedgar3
of the funds on file reporting a position in MEDP
n-portas of Jun 30 '26696
managers reporting a position in thirteen F filings
13fJun 30 '26+17.34%
change in shares held by the ten largest reporting managers
13fJun 30 '26the bear case· 3
11 of 24
of the largest reporting managers cut their stake in the latest quarter
13fJun 30 '2650
managers whose positions together make up four fifths of reported value
13fJun 30 '260.41%
of First Trust Large Cap Growth AlphaDEX Fund assets as largest fund weight
n-portApr 30 '26Sides and captions by the model; every figure is ours. Built Sep 16 '26 for the Oct 26 '26 report. Not a forecast, not advice.
Medpace Holdings, Inc. has no measured co-movers clearing our correlation floor, so only its SEC classification is shown.
SIC 8731, Services-Commercial Physical & Biological Research, from each company's own filings. Largest first.
699 managers report a position worth $13.2B between them, and 50 of them hold 80% of it.
tall tick = annual report · 1 on record
MEDP (Medpace Holdings, Inc.) has 4 disclosed suppliers and 0 disclosed customers, strongest disclosure first.
Suppliers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.